Cardiovascular Risk in Survivors of Stroke

American Journal of Preventive Medicine

Volumn 32, Issue 5, 2007, Pages 408-412

  Kopunek, Susan P ^a   Michael, Kathleen M ^a,b   Shaughnessy, Marianne ^b,c   Resnick, Barbara ^c   Nahm, Eun Shim ^c   Whitall, Jill ^a   Goldberg, Andrew ^a,b   Macko, Richard F ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DYSLIPIDEMIA; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; OBESITY; PHYSICAL EXAMINATION; PREVALENCE; RECURRENT DISEASE; RISK FACTOR; SCREENING; SMOKING; STROKE; SURVIVAL RATE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BALTIMORE; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; STROKE; SURVIVORS;

EID: 34247550151     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2007.01.021     Document Type: Article

References (20)

1. Robinson J.G., and Maheshwari N. A "poly-portfolio" for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years. Am J Cardiol 95 3 (2005) 373-378
2. Qureshi A.I., Suri M.F., Kirmani J.F., and Divani A.A. The relative impact of inadequate primary and secondary prevention on cardiovascular mortality in the United States. Stroke 35 10 (2004) 2346-2350
3. Sacco R.L., Adams R., Albers G., Alberts M.J., Benavente O., Furie K., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37 2 (2006) 577-617
4. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 6 (2003) 1206-1252
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 285 19 (2001) 2486-2497
6. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. Obes Res 2 Suppl (1998) 51S-209S 6
7. Diagnosis and classification of diabetes mellitus. Diabetes Care 28 Suppl 1 (2005) S37-S42
8. Vermeer S.E., Sandee W., Algra A., Koudstaal P.J., Kappelle L.J., and Dippel D.W. Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke. Stroke 37 6 (2006) 1413-1417
9. Ogden L.G., He J., Lydick E., and Whelton P.K. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 35 2 (2000) 539-543
10. Ostwald S.K., Wasserman J., and Davis S. Medications, comorbidities, and medical complications in stroke survivors: the CAReS study. Rehabil Nurs 31 1 (2006) 10-14
11. Sadler G.R., Escobar R.P., Ko C.M., White M., Lee S., Neal T., et al. African-American women's perceptions of their most serious health problems. J Natl Med Assoc 97 1 (2005) 31-40
12. Fonarow G.C., Gawlinski A., Moughrabi S., and Tillisch J.H. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 87 7 (2001) 819-822
13. Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 2 (2004) 227-239
14. Holloway R.G., Benesch C., and Rush S.R. Stroke prevention: narrowing the evidence-practice gap. Neurology 54 10 (2000) 1899-1906
15. Kalra L., Perez I., and Melbourn A. Stroke risk management: changes in mainstream practice. Stroke 29 1 (1998) 53-57
16. Qureshi A.I., Suri M.F., Mohammad Y., Guterman L.R., and Hopkins L.N. Isolated and borderline isolated systolic hypertension relative to long-term risk and type of stroke: a 20-year follow-up of the national health and nutrition survey. Stroke 33 12 (2002) 2781-2788
17. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358 9287 (2001) 1033-1041
18. Bhatt D.L., Steg P.G., Ohman E.M., Hirsch A.T., Ikeda Y., Mas J.L., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. Jama 295 2 (2006) 180-189
19. Dhamoon M.S., Sciacca R.R., Rundek T., Sacco R.L., and Elkind M.S. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology 66 5 (2006) 641-646
20. Schneider A.T., Pancioli A.M., Khoury J.C., Rademacher E., Tuchfarber A., Miller R., et al. Trends in community knowledge of the warning signs and risk factors for stroke. Jama 289 3 (2003) 343-346